Skip to main content
painEvidence: Grade B

Using Your MitoRed MitoPRO 300 for Neuropathy Treatment

Published: Last updated:

Device-specific protocol for Neuropathy using the MitoRed MitoRed MitoPRO 300 (630/660/830/850nm, 168 mW/cm²)

Your MitoRed MitoPRO 300 Protocol for Neuropathy

Wavelengths

630nm, 660nm, 830nm, 850nm

Session Time

1 min

Target Dose

12 J/cm²

Distance

6 inches

Frequency

3-5x/week

Timeline

4-12 weeks

Why MitoRed MitoPRO 300 for Neuropathy?

The MitoRed MitoRed MitoPRO 300 emits at 630nm and 660nm and 830nm and 850nm, which provides a excellent match for Neuropathy treatment. Research for this condition recommends 830nm, 850nm.

At 168 mW/cm² irradiance (at the recommended distance of 6 inches), you'll need approximately 1 minutes per session to reach the target dose of 12 J/cm². This falls within the recommended range of 4-20 J/cm² for Neuropathy.

The MitoRed MitoPRO 300 is a panel device with targeted coverage. For Neuropathy, you may need to treat each area separately if the affected zone is larger than the device's coverage.

MitoRed MitoPRO 300 Quick Specs

Price

$399

LEDs

60

Power

120W

FDA

Not registered

Evidence for Neuropathy

Near-infrared therapy at 830-850nm shows encouraging results for diabetic peripheral neuropathy, with some studies reporting improved sensation and reduced pain scores. Dose: 4-20 J/cm², 15-30 minutes, 3-5x/week for 4-12 weeks. Evidence grade: B (moderate — small but consistent study results).

Same Condition, Different Devices

Research Basis

This content is informed by 47+ published peer-reviewed studies on photobiomodulation.